Variables | Median (IQR) or mean (SD) or n (%) |
---|---|
Age | 49 (40 to 62) |
Sex (male) | 24 (53.3%) |
Comorbidities | |
Hypertension | 11 (24.0%) |
Diabetes | 7 (15.5%) |
Immunosupressiona | 10 (22.2%) |
Chronic respiratory diseaseb | 6 (13.3%) |
Reason for admission | |
COVID-19 pneumonia | 36 (80.0%) |
Non-COVID pneumonia | 5 (11.1%) |
Other | 4 (8.8%) |
Type of acute respiratory failure | |
De novo AHRF | 41 (92.2%) |
Postextubation support | 4 (8.8%) |
HFNO characteristics at inclusion | |
Hours of HFNO therapy | 24 (10 to 48) |
FIO2 | 0.50 (0.45 to 0.60) |
Flow (L/min) | 50 (40 to 50) |
Severity scores | |
SAPS3 | 45 (39 to 52) |
APACHE II | 8.5 (5.0 to 15.3) |
SOFA | 3 (3 to 3) |
Outcomes | |
ICU length of stay (days) | 8 (5 to 15) |
Need for mechanical ventilation | 12 (26%) |
Days of mechanical ventilation | 9 (8 to 14) |
ICU mortality | 2 (4.4%) |
Hospital length of stay (days) | 16 (9 to 30) |
Hospital mortality | 4 (4.4%) |